Cytoplast

Cytoplast is a biotechnology company developing a novel class of cell-based medicines using engineered enucleated cells, known as "Cytoplasts." By removing the nucleus, the company creates therapeutic vehicles that retain the biological complexity and homing capabilities of living cells while eliminating the risks of uncontrolled proliferation or genetic instability. The company's platform focuses on delivering potent therapeutic payloads, such as cytokines or enzymes, directly to disease sites like solid tumors or inflamed tissues. Cytoplast aims to overcome the limitations of traditional cell therapies by providing a safer, more controllable, and "off-the-shelf" approach to treating complex diseases. The technology is based on pioneering work in cell engineering and enucleation processes, allowing for precise control over therapeutic delivery.